Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 395Neoplasms 350Carcinoma, Non-Small-Cell Lung 313Prostatic Neoplasms 264Colorectal Neoplasms 236Lung Neoplasms 204Multiple Myeloma 163Pancreatic Neoplasms 147Ovarian Neoplasms 146Neoplasm Metastasis 141Leukemia, Myeloid, Acute 138Melanoma 118Squamous Cell Carcinoma of Head and Neck 100Carcinoma, Renal Cell 93Stomach Neoplasms 92Recurrence 92Lymphoma 91Lymphoma, Non-Hodgkin 89Endometrial Neoplasms 89Carcinoma, Hepatocellular 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 87Glioblastoma 85Brain Neoplasms 84Head and Neck Neoplasms 77Glioma 76Uterine Cervical Neoplasms 75Urinary Bladder Neoplasms 72Sarcoma 70Leukemia, Lymphocytic, Chronic, B-Cell 70Hematologic Neoplasms 68

Interventions

Clinical Trials, Phase IV as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Advanced Cancer × 30 days × Clear all
NCT07605962 2026-06-03

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

United Immunity, co., Ltd.

Phase 1/2 Recruiting
140 enrolled

Advanced Cancer

NCT02455505 2026-06-02

Identifying Family Members in Need of Support While Caregiving and After Loss

Memorial Sloan Kettering Cancer Center

Active not recruiting
52 enrolled

Advanced Cancer

NCT07408310 2026-06-02

Trial of Spiritual Care Interventions for Patients With Cancer

Weill Medical College of Cornell University

Phase NA Recruiting
288 enrolled

Advanced Cancer

NCT02112188 2026-05-22

Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer

Memorial Sloan Kettering Cancer Center

Active not recruiting
84 enrolled

Advanced Cancer

NCT06656390 2026-05-22

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Shanghai Allink Biotherapeutics Co., Ltd.

Phase 1/2 Recruiting
202 enrolled
Other solid neoplasm

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡